Knock-in
EditCo Bio and Promega Partner to Power a New Era of Biologically Relevant Cell-Based Research
April 22, 2025
| EditCo
EditCo’s robust, HiBiT-tagged CRISPR knock-ins transform cells into powerful biosensors — perfect for drug discovery, cell-based assays, and protein...
Read More
Biocompare Editorial Article: CRISPR Genome Editing Advances Disease Modeling
March 20, 2025
| Biocompare
This Editorial article was published on Biocompare.
Read More
Press
EditCo Bio, Inc. Launches XDel Knockout Cells: Redefining CRISPR Gene Editing Efficiency and Reproducibility
January 28, 2025
| EditCo
REDWOOD CITY, Calif.--EditCo Bio, a leader in cutting-edge genetic engineering and cellular model solutions, today announced the launch of XDel...
Read More
Press
Viewpoints: The Evolution of CRISPR Technology
August 27, 2024
| Travis Hardcastle
This article is also published on Biocompare.
Read More
EditCo Bio, Inc. Unveils Novel Knockout CD4+ T-cell Pools to Transform Cancer and Autoimmune Research
April 18, 2024
| EditCo
REDWOOD CITY, CA, April 18, 2024 – EditCo Bio, Inc., a pioneer at the forefront of genome engineering innovation, today announced the launch of its...
Read More